Serum Levels of Calreticulin in Correlation with Disease Activity in Patients with Rheumatoid Arthritis

[1] McInnes IB(2011)The pathogenesis of rheumatoid arthritis N Engl J Med 365 2205-2219

[2] Schett G(2005)Diagnosis and management of rheumatoid arthritis Am Fam Physician 72 1037-1047

[3] Rindfleisch JA(2003)Rheumatoid arthritis in 2003: where are we now with treatment? Ann Rheum Dis 62 ii94-ii96

[4] Muller D(2002)Evidence supporting the benefit of early intervention in rheumatoid arthritis J Rheumatol Suppl 66 3-8

[5] Weinblatt ME(2011)Assessment of disease activity and treatment outcomes in rheumatoid arthritis J Manag Care Pharm 17 S09-S13

[6] Emery P(1995)Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44-48

[7] Farheen K(2010)Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study Mod Rheumatol 20 539-547

[8] Agarwal SK(2005)The disease activity score and the EULAR response criteria Clin Exp Rheumatol 23 S93-S99

[9] Prevoo ML(2007)Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan Ann Rheum Dis 66 1221-1226

[10] van’t Hof MA(2004)High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis J Rheumatol 31 1095-1097

[1] McInnes IB(2011)The pathogenesis of rheumatoid arthritis N Engl J Med 365 2205-2219

[2] Schett G(2005)Diagnosis and management of rheumatoid arthritis Am Fam Physician 72 1037-1047

[3] Rindfleisch JA(2003)Rheumatoid arthritis in 2003: where are we now with treatment? Ann Rheum Dis 62 ii94-ii96

[4] Muller D(2002)Evidence supporting the benefit of early intervention in rheumatoid arthritis J Rheumatol Suppl 66 3-8

[5] Weinblatt ME(2011)Assessment of disease activity and treatment outcomes in rheumatoid arthritis J Manag Care Pharm 17 S09-S13

[6] Emery P(1995)Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44-48

[7] Farheen K(2010)Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study Mod Rheumatol 20 539-547

[8] Agarwal SK(2005)The disease activity score and the EULAR response criteria Clin Exp Rheumatol 23 S93-S99

[9] Prevoo ML(2007)Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan Ann Rheum Dis 66 1221-1226

[10] van’t Hof MA(2004)High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis J Rheumatol 31 1095-1097